Navigation Links
Limited transparency in federal nanotech research may hamper development
Date:4/16/2008

Washington, DC Without clear leadership and more transparency in federal risk research investment, the emergence of safe nanotechnologies will be a happy accident, rather than a foregone conclusion, says Dr. Andrew Maynard, the Chief Science Advisor for the Project on Emerging Nanotechnologies (PEN). This sentiment was voiced today by Dr. Maynard in testimony at the House Science & Technology Committees hearing on the National Nanotechnology Initiative Amendments Act of 2008.

Activities to date within the federal nanotechnology initiative have been less than transparent, to the detriment of an effective strategy for nanotechnology development and use, Dr. Maynard says in written testimony submitted to the committee. There is a yawning knowledge-gap between nanomaterials entering commerce now and what we know about their safety. This uncertainty over how to develop nanotechnologies safely is hamstringing regulators, impeding nano businesses, and confusing consumers. In short, moving towards the nanotechnology future without a clear understanding of the possible risks, and how to manage them, is like driving blindfolded.

A PEN assessment of purported nanotechnology risk-relevant research published by the federal governments National Nanotechnology Initiative reveals that spending on environment, health and safety-focused research projects in 2006 was substantially lower than that claimed by U.S. officials.

Research projects with the primary aim of understanding and managing the risks of nanotechnology accounted for only $13 million in funding for 2006, according to Dr. Maynard. Over the same period, European Union nations invested nearly $24 million in similar nanotech risk-focused projectsalmost twice as much as the U.S. There is undoubtedly potentially-relevant research buried in other U.S. government funded projects. But without transparency, it is impossible to assess the true value of this research, or ensure it is used to enable the development of safe nanotechnologies.

In his testimony Dr. Maynard also renews calls for a reorganization of a federal nanotechnology risk research strategy that emphasizes a top-down approach to directing environment, health and safety studies on the cutting-edge technology; urges a minimum of 10 percent of the federal nanotechnology research budget be committed to highly or substantially relevant environmental, health and safety topics a significant increase from current levels; and the creation of public-private partnerships that will leverage more funding for research.

On top of discussing issues pertaining to the federal investment in nanotechnology research, Dr. Maynard addresses his concern with the nano-readiness of Americas students, teachers and workforce in his testimony particularly through his endorsement of initiatives aimed at recruiting and preparing students to pursue education in nanotechnology. The House nanotechnology legislation at issue focuses significant attention on nanotechnology education.

When today China has as many scientists and engineers working on nanotechnology as the U.S., it is critical to support initiatives in nanotechnology education aimed at our young people, Dr. Maynard says.


'/>"/>

Contact: Colin Finan
colin.finan@wilsoncenter.org
202-691-4321
Project on Emerging Nanotechnologies
Source:Eurekalert

Related biology technology :

1. Alimera Sciences, pSivida Limited Amend Medidur(TM) FA Collaboration Agreement
2. Daval International Limited Gains Approval for Phase IIB Trial of AIMSPRO(R)
3. Sunrise Biotech Holding Limited Application For Admission to PLUS
4. RoundTable Healthcare Partners Closes Sale of MedAssist Holding, Inc. to Firstsource Solutions Limited
5. Slow federal action to oversee nanotechnology leaves room at the bottom
6. Hepatitis B Foundation Testifies Before Congressional Appropriation Committee and Urges More Federal Funding for Hepatitis B
7. Federal nanotech risk research plan still comes up short
8. Cephalon Statement on Federal Trade Commission Action Regarding PROVIGIL Patent Settlements
9. Federally-Funded Study Shows More Women Can Avoid Hysterectomy for Common Problem
10. DelSite Nasal Powder Technology Could Reduce Recently Reported Waste in Federal Vaccine Program
11. Zimmer Announces Settlement of Federal Investigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Research and Markets has announced the ... to their offering. ... The Global Market for Bioproducts Should Reach ... a CAGR of 8.9%, This research report ... seven major product segments: bio-derived chemicals, biofuels, pharmaceuticals (biodrugs and ...
(Date:3/23/2017)... , March 23, 2017  SeraCare Life ... global in vitro diagnostics manufacturers and clinical ... industry,s first multiplexed Inherited Cancer reference ... by next-generation sequencing (NGS). The Seraseqâ„¢ Inherited ... with input from industry experts to validate ...
(Date:3/23/2017)... 23, 2017  BioPharmX Corporation (NYSE MKT: BPMX), ... dermatology market, today reported financial results for the ... will provide an update on the company,s clinical ... "We are pleased to report that last ... said President Anja Krammer. "We achieved key clinical ...
(Date:3/23/2017)... 2017 Kineta, Inc., a biotechnology company ... in immuno-oncology, today announced the discovery and characterization ... that activate interferon response factor 3 (IRF3) via ... tumor regression in a murine colon carcinoma mouse ... complete tumor regression to initial drug treatment were ...
Breaking Biology Technology:
(Date:3/9/2017)... VIEW, Calif. , March 9, 2017 ... 23andMe , the leading personal genetics company, are using ... now provide customers with personalized nutrition plans that consider ... but also genetic markers impacting how their body may ... food decision support platform uses biometrics such as Body ...
(Date:3/2/2017)... , March 2, 2017 Summary This ... Perrigo and its partnering interests and activities since 2010. ... Read the ... and Alliance since 2010 report provides an in-depth insight into ... sciences companies. On demand company reports are prepared ...
(Date:3/1/2017)... , March 1, 2017  Aware, Inc. (NASDAQ: ... announced that Richard P. Moberg has resigned, ... co-President and Chief Financial Officer and Treasurer of Aware ... to serve as a member of the Board of ... , Aware,s co-Chief Executive Officer and co-President, General Counsel ...
Breaking Biology News(10 mins):